CMPX Stock-Based Compensation
Compass Therapeutics · Stock-Based Compensation
CMPX Stock-Based Compensation
Latest reported$12.96Mperiod ending
CMPX TTM Stock-Based Comp ($475.44K → $12.96M)
TTM stock-based compensation
High-resolution chart · PNG
CMPX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 12,958,000 | |
| 10,927,000 | |
| 8,368,000 | |
| 8,781,000 | |
| 9,741,000 | |
| 9,071,000 | |
| 8,560,000 | |
| 7,922,000 | |
| 7,349,000 | |
| 6,856,000 | |
| 6,120,000 | |
| 5,545,000 | |
| 5,207,000 | |
| 5,023,000 | |
| 5,330,000 | |
| 5,491,000 | |
| 5,191,000 | |
| 4,655,000 | |
| 4,029,000 | |
| 3,893,000 | |
| 5,442,000 | |
| 4,717,000 | |
| 4,016,000 | |
| 3,192,000 | |
| 905,000 | |
| 722,185 | |
| 475,440 | |
| 249,440 |